MétaCan
Menu
Back to cohort

Hemorrhages during Escitalopram—Venlafaxine— Mirtazapine Combination Treatment of Depression

2005· letter· en· W5668500 on OpenAlexvenueno aff
Franco Benazzi

Bibliographic record

VenueThe Canadian Journal of Psychiatry · 2005
Typeletter
Languageen
FieldMedicine
TopicElectroconvulsive Therapy Studies
Canadian institutionsnot available
Fundersnot available
KeywordsEscitalopramMirtazapineVenlafaxineReuptake inhibitorAnesthesiaDoseMedicineVenlafaxine HydrochlorideAntidepressantPsychologyInternal medicinePsychiatryAnxiety

Abstract

fetched live from OpenAlex

Dear Editor: Selective serotonin reuptake inhibitors (SSRIs) may cause bleeding (1-3), probably by increasing platelet release of serotonin, which increases platelet aggregation. I report on a patient who experienced bleeding during treatment for depression when escitalopram, venlafaxine, and mirtazapine were combined but not when the same drugs were used alone. Case Report A man, aged 60 years, with major depressive disorder had been treated for 12 months with many antidepressants, both alone and in combination, with mild improvement. All SSRIs had been used alone at maximum dosage. The maximum dosages of venlafaxine alone and mirtazapine alone (which increase serotonin and norepinephrine) had also been used. The patient improved with escitalopram 20 mg daily. Two months later, because his depressive symptoms persisted, venlafaxine and mirtazapine were added to escitalopram. His mirtazapine dosage was 15 mg daily, and his venlafaxine dosage was 150 mg daily. One week later, the patient noted mild hemorrhages from his nose and rectum. These progressively worsened during the following 3 weeks, but not to the point of requiring emergency treatment. The patient then spontaneously gradually reduced the dosages of mirtazapine, venlafaxine, and escitalopram. Mirtazapine was reduced to 7.5 mg daily, venlafaxine to 100 mg daily, and escitalopram to 15 mg daily. In 1 week, the bleeding decreased. He continued weekly tapering the medications to escitalopram 5 mg daily, venlafaxine 37.5 mg daily, and mirtazapine 7.5 mg daily after 3 weeks. During tapering, the amount of nose and rectal blood loss progressively decreased; it stopped when the final dosages were reached. As well, the patient's depression remitted. He experienced no serotonin syndrome. This patient has also been taking omeprazole 20 mg daily for stomach ulcers he developed years ago, as well as, for some years, the antihypertensive irbesartan (an angiotensin II receptor inhibitor) 300 mg daily. The onset of hemorrhages when mirtazapine and venlafaxine were added to escitalopram and the dosage-response relation between bleeding and dosages of these drugs suggest a causal link: Because previous treatments with escitalopram, venlafaxine, and mirtazapine, used alone, did not cause hemorrhages, it appears that this drug combination may have caused them. Escitalopram and venlafaxine (by blocking serotonin reuptake) and mirtazapine (by increasing serotonin release) may have increased serotonin to levels not reached with previous treatments, leading to hemorrhage by platelet aggregation. …

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.009
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Case report · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.005
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.009
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0010.001
Scholarly communication0.0020.002
Open science0.0020.000
Research integrity0.0050.005
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.012
GPT teacher head0.254
Teacher spread0.242 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designCase report
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations12
Published2005
Admission routes1
Has abstractyes

Explore more

Same venueThe Canadian Journal of PsychiatrySame topicElectroconvulsive Therapy StudiesFrench-language works237,207